Immatics N.V.

NASDAQ:IMTX

Biotechnology

Healthcare
$5.95 +1.58%

+$0.15 today

Market cap
$890.33M
Beta
1.30
P/E (TTM)
-5.3
EPS (TTM)
-$1.59
52W Low $5.05High $12.41

Volume 0.99M

Average 0.46M

Income Statement

Follow revenue through to earnings.

Revenue

$48.27M

FY 2025 · Annual

-69.0% YoY

Operating Income

-$182.02M

FY 2025 · Annual

Net Income

-$196.45M

FY 2025 · Annual

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue34.76M172.83M54M155.84M48.27M
Cost of Revenue87.57M106.78M118.66M00
Gross Profit(52.81M)66.05M(64.67M)155.84M48.27M
Gross Margin-151.9%38.2%-119.8%100.0%100.0%
Research & Development87.57M106.78M118.66M148.08M183.83M
Selling, General & Admin33.81M36.12M38.2M46.45M51.18M
Operating Expenses121.05M142.88M155.72M194.45M230.28M
Depreciation & Amortization5.47M6.84M7.23M12.23M12.4M
EBITDA(87.3M)50.04M(88.93M)34.46M(185.09M)
EBITDA Margin-251.1%29.0%-164.7%22.1%-383.5%
Operating Income(86.29M)29.95M(101.73M)(38.62M)(182.02M)
Operating Margin-248.2%17.3%-188.4%-24.8%-377.1%
Interest Income133K2.48M13.85M25M17.18M
Interest Expense566K1.04M831K886K946K
Other Income / Expenses(7.04M)12.08M4.73M59.96M(16.42M)
Income Before Tax(93.34M)42.04M(96.99M)21.35M(198.44M)
Pre-Tax Margin-268.5%24.3%-179.6%13.7%-411.1%
Income Tax Expense04.55M06.13M(1.99M)
Net Income(95.06M)37.51M(96.99M)15.22M(196.45M)
Net Margin-273.5%21.7%-179.6%9.8%-407.0%
EPS (Basic)(1.51)0.55(1.20)0.14(1.54)
EPS (Diluted)(1.51)0.54(1.20)0.14(1.54)
Weighted Avg Shares62.91M67.22M80.55M108.7M122.35M
Weighted Avg Shares (Diluted)62.91M68.82M80.55M106.8M122.35M

IMTX Earnings Waterfall · TTM

NASDAQ:IMTX · Revenue to Net Income

Key Ratios

EPS$-1.71
Gross Margin100.0%
Net Margin-849.9%
P/E Ratio-4.8
P/S Ratio123.7

Analysis

$37.3M of revenue converted into -$214.4M of net income for the selected period. Gross margin is 100.0% and net margin is -849.9%, showing how much revenue survives after costs and taxes. EPS is $-1.71, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
6-K6-K filingNov 10, 2026
6-K6-K filingOct 26, 2026
6-K6-K filingOct 23, 2026
4Statement of changes in beneficial ownershipAug 27, 2026

How much revenue does IMTX generate?

Immatics N.V. (IMTX) reported $48.27M of revenue in fiscal 2025.

Is IMTX profitable?

Immatics N.V. (IMTX) reported -$196.45M of net income, with a net margin of -407.0%.